Anna Schultze, PhD, MSc

Assistant Professor
London School of Hygiene and Tropical Medicine
London, United Kingdom

Anna is a pharmacoepidemiologist in the Electronic Health Records Group at LSHTM. Before joining LSHTM, Anna worked as a senior research associate at the consultancy firm Evidera, where she designed and managed post-authorisation safety and comparative effectiveness studies, primarily using nationwide Scandinavian health registries. She completed a PhD in epidemiology at UCL in 2017, focusing on HIV drug resistance, and also holds an MSc in Epidemiology from LSHTM and a BSc in Human Sciences from UCL.

Disclosure information not submitted.

Presentation(s):

• Advanced Methods I: Let's GIT It Started: Transparency and Reproducibility Across the RWE Study Lifecycle with HARPER, GIT and the R Programming Language

  Sunday, August 25, 2024
  9:00 AM – 12:30 PM CEST

• Applying the self-controlled case series to analyse safety endpoints in single-arm, open label extension studies: A case study of Belimumab for the treatment of systemic lupus erythematosus and risk of infection

  Monday, August 26, 2024
  1:30 PM – 1:45 PM CEST

• A comparison of self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases

  Monday, August 26, 2024
  5:15 PM – 5:30 PM CEST

• Using probabilistic bias analysis to account for outcome misclassification of COVID-19 death in pharmacoepidemiologic studies

  Tuesday, August 27, 2024
  1:15 PM – 1:30 PM CEST

• Ursodeoxycholic acid and severe COVID-19 outcomes in people with liver disease: a cohort study using the OpenSAFELY platform

  Tuesday, August 27, 2024
  1:30 PM – 1:45 PM CEST